Evidence map›Paper›PMID 40394030›Full record

ArticleScientific reports2025

The impact of pre-existing aortic stenosis and mitral regurgitation on patients with acute myocardial infarction.

Tamilla Muzafarova, Zuzana Motovska, Petr Kala, Ota Hlinomaz, Milan Hromadka, Teodora Vichova, Jan Mrozek, Marek Šramko, Martin Hutyra, Robert Petr and 5 more

Erratum issuedAbstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Tamilla MuzafarovaCardiocentre, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Srobarova 50, Prague, 10034, Czech Republic.
Zuzana MotovskaCardiocentre, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Srobarova 50, Prague, 10034, Czech Republic. zuzana.motovska@lf3.cuni.cz.
Petr KalaDepartment of Internal Medicine and Cardiology, Faculty of Medicine of Masaryk University and University Hospital Brno, Brno, Czech Republic.
Ota HlinomazFirst Department of Internal Medicine - Cardioangiology ICRC Faculty of Medicine of Masaryk, University and St. Anne's University Hospital, Brno, Czech Republic.
Milan HromadkaDepartment of Cardiology, Faculty of Medicine in Pilsen, University Hospital, Charles University, Pilsen, Czech Republic.
Teodora VichovaCardiocentre, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Srobarova 50, Prague, 10034, Czech Republic.
Jan MrozekCardiovascular Department University Hospital Ostrava, Ostrava, Czech Republic.
Marek ŠramkoDepartment of Cardiology Institute for Clinical and Experimental Medicine, Olomouc, Czech Republic.
Martin HutyraFirst Internal, Cardiology Clinic University Hospital Olomouc, Olomouc, Czech Republic.
Robert PetrCardiology Prague Ltd, Prague, Czech Republic.
Pavol TomasovLiberec Regional Hospital, Liberec, Czech Republic.
Oana IonitaCardiocentre, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Srobarova 50, Prague, 10034, Czech Republic.
Pilar Lopez SantiLeiden University Medical Centre, Leiden, Netherlands.
Aileen Paula ChuaLeiden University Medical Centre, Leiden, Netherlands.
Jiri JarkovskyInstitute of Biostatistics and Analyses Faculty of Medicine, Masaryk University, Brno, Czech Republic.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prevalence of left-sided valvular heart disease (VHD) increases with age, but data on the impact of pre-existing VHD in patients with acute myocardial infarction (AMI) are limited. We aimed to define the clinical characteristics and outcomes of AMI patients with pre-existing left VHD. The analysis is based on data from three merged national registries. The dataset included 47,436 patients admitted with AMI over a 5year period at all Cath Labs nationwide. Pre-existing VHD was diagnosed in 1,445 patients (3.0%), moderate-to-severe mitral regurgitation (MR) in 510 patients (35.3%), and moderate-to-severe aortic stenosis (AS) in 869 patients (60.1%). Patients with VHD had worse baseline characteristics, pre-existing coronary artery disease, more complicated in-hospital course with higher Killip class, lower left ventricular ejection fraction, and more comorbidities. Angiographically more frequent left main stenosis, TIMI flow 3 before PCI, less frequent stent implantation. Patients with pre-existing VHD had significantly higher 7-day (10.1% vs. 4.5%, p < 0.001), 30-day (16.0% vs. 7.0%, p < 0.001) and 1-year mortality (28.7 vs. 12.7%, p < 0.001) compared to patients without. Conclusions. Patients with pre-existing VHD and AMI are characterized by complicated in-hospital course with higher Killip class, lower ejection fraction, angiographically less severe stenosis, TIMI flow 3 prior to PCI, and less frequent stent implantation. This is a high-risk group with higher short - and long-term mortality and earlier intervention should be considered.

Indexed as

Aortic Valve StenosisMitral Valve InsufficiencyMyocardial InfarctionAgedAged, 80 and overFemaleHumansMaleMiddle AgedRegistriesRisk Factors

Identifiers

PMID40394030
PMCPMC12092825

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.